Form 4: Aehr Test Systems: Insider Transaction Disclosure
Insider Transaction Report (Form 4)
Didier Wimmers, Executive VP of R&D at Aehr Test Systems, reported a transaction involving the withholding of shares for tax obligations.
Summary
- Didier Wimmers, Executive VP of R&D at Aehr Test Systems, filed a Form 4 statement detailing a transaction on June 3, 2026.
- The transaction involved 332 shares of common stock, with a price of $114.59 per share.
- These shares were withheld to satisfy tax withholding obligations upon the vesting of restricted stock units.
- This action does not represent a sale of shares by the reporting person.
- Following this transaction, Mr. Wimmers beneficially owns 10,327 shares of common stock.
- The reported amount includes shares subject to unvested restricted stock units.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine administrative transaction related to executive compensation rather than a strategic business development or financial performance indicator.
Positives
- The transaction is a standard procedure for satisfying tax obligations on vested equity, indicating continued equity participation by management.
- The reporting person continues to hold a significant number of shares (10,327), suggesting confidence in the company.
Negatives
- The withholding of shares for tax purposes, while routine, reduces the immediate number of shares available to the reporting person.
Risks
- The filing does not explicitly mention any new risks. However, the value of the withheld shares is subject to market fluctuations.
- The presence of unvested restricted stock units implies that a portion of the reported ownership is contingent on future performance or vesting schedules.
Future Outlook
The filing does not contain forward-looking statements or guidance. It is a report of a past transaction.
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for Section 16 reporting persons and are crucial for transparency in insider trading. The details provided are typical for equity compensation plans and tax settlements.
Comparison to Industry Standards
- This type of transaction (share withholding for tax on RSUs) is a common practice across the technology and semiconductor industry, including companies like Applied Materials, Lam Research, and KLA Corporation, where equity compensation is a significant part of executive remuneration.
- The price of $114.59 per share reflects the market value at the time of the transaction, which is subject to the overall market conditions and the specific performance of Aehr Test Systems relative to its peers.
Stakeholder Impact
- Shareholders: The transaction itself does not directly impact share count or company value, but it confirms management's continued equity stake.
- Employees: The transaction is specific to Didier Wimmers and his equity compensation, not a general employee benefit.
- Management: Confirms the standard process of equity vesting and tax settlement for executives.
Next Steps
- Continued monitoring of Didier Wimmers' beneficial ownership and any future transactions.
- Observation of Aehr Test Systems' overall financial performance and strategic developments.
Key Dates
| Date | Description |
|---|---|
| 06/03/2025 | Date of execution for the Power of Attorney document. |
| 06/03/2026 | Transaction Date for the Form 4 filing. |
| 06/04/2026 | Date of signature for the Form 4 filing. |
Keywords
Form 4, Insider Transaction, Aehr Test Systems, Didier Wimmers, Executive VP R&D, Restricted Stock Units, Tax Withholding, Beneficial Ownership, Equity Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.